glp 1 dose conversion chart Zepbound to Wegovy GLP-1/GIP Ratio : r/Zepbound glp 1 dose conversion chart
Description
Glucose-sensing in glucagon-like peptide-1-secreting cells
Clinical trials show average weight loss of 10-20% of body weight over 68 weeks
Cardiovascular side effects with semaglutide are generally mild, and the SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (MACE) in people with established heart disease
Among the dual GLP-1R/GIP-R agonists, tirzepatide has a high albumin affinity, thus an increased half-life of 5 days
